Alzheimer’s disease (AD) and cerebral ischemia (CI) are neuropathologies that are characterized by aggregates of tau protein, a hallmark of cognitive disorder and dementia. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.